Eat It Up: The Best Delta-8 THC Edibles on the Market
Edibles have become a new and loved way of consuming cannabis. But not every cannabis edible is the same. Not only can you get full spectrum cannabis edibles, but you can get pure CBD edibles, and delta-8 THC edibles too, meaning all the great delta-8 benefits of smoking, can be accessed through eating. So, here’s a look at the best delta-8 THC edibles on the market today.
Delta-8 THC is quickly becoming a preferred type of cannabis with tons of options for how to consume it, from edibles to oils to vapes, and so on. Its popularity is related to its lesser psychoactive effect, lack of anxiety, and clear-headed high. If you’re interested in finding out what all the hype is about, check out our awesome delta-8 THC deals, and figure out which delivery method works best for you.
What is delta-8 THC
If the whole point of creating delta-8 THC edibles is to give users an alternative to standard THC, the first question is, why is this beneficial? And the answer, is that using delta-8 THC over delta-9 THC, affords users certain specific benefits that make delta-8 preferable. We’ll get to those in a minute, but first, what exactly is delta-8?
Delta-8 THC is a naturally occurring derivative of delta-9 THC, which means, it occurs in nature on its own. This is different than something like delta-10 THC which is never seen in nature, and must be created in a lab. Delta-8 occurs when delta-9 comes into contact with oxygen, which makes it lose elections (oxidize) to form delta-8 THC. The chemical structure of the two is actually the same (C₂₁H₃₀O₂), and the only difference in structure is the placement of a double carbon bond. In delta-9 it sits on the 9th atom in the chain, for delta-8, on the 8th. Want to guess where that double bond is for the synthetic delta-10? If you guessed the 10th atom, you’re correct!
In terms of what it does differently, there are a few factors which make it noteworthy. First of all, it has nearly all of the same positive health aspects as delta-9. Among other things, it’s an antimicrobial, an anti-inflammatory, it’s good for neurological and spastic disorders, it helps with nausea and vomiting, as well as appetite stimulation, and it can help with anxiety and insomnia.
This last one mentioned is important. Not only can delta-8 THC help with anxiety, but it’s known for producing less of it in the first place, an aspect that makes it preferable to delta-9, which causes anxiety and paranoia in many users. These are not issues with delta-8 THC, which is known for producing a more clear-headed high, with more energy and less couch-locking. It also comes with less psychoactive effect, so for those looking to it for its medical value, it can be used without as much of a high, while still providing a smaller one for those who want to feel something.
Is it legal?
Delta-8 THC has been known about since 1965 when it was first synthesized by Dr. Rafael Mechoulam in Israel. However, it made a major re-emergence in the wake of the 2018 US Farm Bill which legalized the cultivation of hemp and the production of hemp products. For a time it seemed that since delta-8 could be sourced from any delta-9, including delta-9 from low-THC hemp plants, that it could be a legal THC alternative by slipping into the industrial hemp loophole. However, that legal gray area has been considerably weakened by different factors.
One is the definition of synthetic. Though delta-8 occurs naturally in nature, it occurs at extremely low concentrations, meaning if a product is going to be made from it, it requires human production help. Whether or not this fits the definition of ‘synthetic’ has not been made clear by either the DEA Interim Final Rule that came out in 2020 to better clarify rules of hemp production, or the USDA Final Rule, which also didn’t touch the subject.
The other issue is also rather confounding. While delta-9 THC in hemp is considered legal under the definition of hemp, so long as the plant its sourced from doesn’t contain above .3% THC, further clarifications of the Farm Bill made clear that not only does the plant need to constitute no more than that amount of THC, but so must all stages of processing, including the final product. This, of course, would rule out any product that is meant to be primarily delta-8 THC. But, technically, this still doesn’t illegalize it, just makes the idea of it less useful.
It should be mentioned, that though some locations are putting in the effort to specifically illegalize it, the federal government has done nothing to stop its production, perhaps signally that it understands its inability to control it, legal or not. And so at least for now, the loophole seems to hold, even if its mainly based in imagination.
And now, why edibles?
We’ve gone over why using delta-8 THC might be preferable for some people over delta-9, but why use it in edible form? There are a couple answers to this question, the first – and maybe most important – being that eating a cannabis product will almost uniformly cause less damage than vaping or smoking. Though vaping is a clearly safer alternative to smoking, the lack of useful regulation in what can be used in vape cartridges and the processing for these compounds, leaves the door open for danger, as evidenced by issues with vitamin-E acetate. That notwithstanding, vaping is generally safe, however not messing with the lungs at all…is often a better idea.
NEW: DELTA 10 THC
The other benefit is that edibles produce a longer, stronger high. When cannabis is inhaled, it goes directly to the lungs, and then the bloodstream, and then to the brain, where it attaches to CB1 receptors, which makes a person feel high. This all happens so fast that it feels like the high is pretty instantaneous. A general smoking (or vaping) high will last around 1-2 hours. When eaten, the THC goes through the stomach, and active compounds are sent to the liver for metabolization. Here the standard delta THC (C₂₁H₃₀O₂), is converted to something called 11-Hydroxy-THC (C21H30O3). This stronger version lasts way longer than standard THC, giving a high that lasts 4-6+ hours.
One of the main detractions of edibles is that they take a while to kick in. Going though the digestive tract to the liver takes time, and a user might have to wait 45 minutes to three hours to feel effects. This is irritating to begin with, but can become problematic if the user inadvertently takes more than required, thinking that they haven’t taken enough while waiting. Though this won’t kill anyone, it sure can make a user feel like they’re going to die, and that’s no fun at all. For this reason, edibles in dispensaries will always come in specific amounts, with instructions to start with low doses, and increase very slowly over a long period of time.
Best delta-8 THC edibles for your sweet tooth
The ability to use an alternate version of THC with slightly different properties, doesn’t stop at smoking it. Delta-8 THC can be found in tons of edible products, here are some of the best, and most interesting, delta-8 THC edibles to try.
The company 3chi certainly jumped on the delta-8 THC edibles bandwagon. The company has a line of awesome products including two types of gummies. First there’s delta-8 THC gummies, with 25 mg of delta-8 each, that come in packs of eight or 16, and are completely vegan and gluten-free. Their other option is the fantastically named Comfortably Numb Delta 8 THC:CBN Gummies, with a 1:1 ratio of delta-8 to CBN (25 mg each), coming in both eight and 16 packs as well.
Another option is Ounce Of Hope’s delta-8 gummies that come in packs of four or 20, each containing 20 mg of delta-8 THC. Yet another option is Cannabis Prime, and its massive array of delta-8 candies, including Gummy Bears, Blue Raspberry Rings, Strawberry Puffs, Fruit Slices, Cherry Drops, and more, all available with either 120 or 300 mg of delta-8.
Cannabis Meets Crypto at Grapefruit’s New CBD Hourglass E-Commerce Store
E-Crypto News’ update provides the latest articles on technology and cryptocurrencies.
Is it Time to Start Watching CBD Stocks Like CWBHF, MJNA, RLBD, and CRON?
One of the most significant growth trends in the world today is in CBD products. This was also one of the most significant market booms of the past half-decade. But no one seems to remember it. That should be a clue.
When a market theme gets too popular, it’s time for the late money and the weak-handed money to get burnt. But, if the fundamental trend remains in place, then the theme will resurface once the over-eager speculators have been cleared out.
According to recent research from ResearchAndMarkets.com, the global cannabidiol market is expected to reach $13.4 billion by 2028, growing at a CAGR of 21.2% from 2021 to 2028.
It’s time to start watching for the re-emergence of this theme.
This is especially true given the evolution of the companies involved and the overall dynamics that define the space. With that in mind, we take a look at a handful of interesting prospects in the space here, including Charlotte’s Web Holdings Inc (OTC US: CWBHF), Medical Marijuana Inc (OTC US: MJNA), Real Brands Inc (OTC US: RLBD), and Cronos Group Inc (NASDAQ: CRON).
Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) bills itself as a company that develops and distributes hemp-based cannabidiol (CBD) wellness products. Its products include CBD hemp oils, capsules, topicals, and pet products that feature CBD hemp oil extracts.
Charlotte’s Web Holdings, Inc. sells its products online as well as through distributors, and brick and mortar retailers. Charlotte’s Web current product categories include tinctures (liquid products), capsules, topical, as well as pet products. Charlotte’s Web hemp-based whole plant extracts are sold through select distributors, brick and mortar retailers, and online through the Company’s website.
CWBHF recently reported financial results for the first quarter ended March 31, 2021, including highlights such as the fact that consolidated revenue increased 9.1% to $23.4 million vs. $21.5 million in Q1-2020, DTC eCommerce sales increased 14.5% year-over-year and contributed 68.9% of Q1 revenue, and B2B net revenue decreased 1.4% year-over-year.
“Despite reduced retail activity due to the pandemic, our directly comparable B2B retail sales showed year-over-year growth. Our B2B retail sales and velocities further strengthened in March and April as US vaccination programs support reopening of the economy, and our DTC sales continued to grow demonstrating long-term secular strength for our products in the e-commerce channel,” said Deanie Elsner, CEO of Charlotte’s Web. “We continued to expand our leading market position with quarterly market share gains across all of our channels. Internationally we have made our first moves into Israel and Canada with initial product sales planned for early 2022. We are pleased with our progress and believe that Charlotte’s Web is well-positioned to drive continued growth in the US and new growth in key international markets as we expand outside of the US.”
The stock has suffered a bit of late, with shares of CWBHF taking a hit in recent action, down about -14% over the past week.
Charlotte’s Web Holdings managed to rope in revenues totaling $35.1M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 16.4%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($67.3M against $36.9M).
Medical Marijuana Inc (OTCMKTS: MJNA) bills itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.
The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry.
MJNA recently announced that its subsidiary HempMeds® Brasil had its best revenue month ever in Company history in April 2021. “Our HempMeds Brasil operations have seen a consistent increase over the years. We aim to reach as many consumers in need as possible and last month’s achievements prove that we are continuing to expand our reach to our target audiences,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
“I am incredibly proud of the success our HempMeds Brasil team has been able to achieve. As we celebrate our best revenue month in company history, we are scaling our operations in the country, refreshing our consumer-facing website, and increasing the size of our facilities in Brazil to meet the needs of our expanding team,” said HempMeds® CEO Raul Elizalde.
If you’re long this stock, then you’re liking how it has responded to the announcement. MJNA shares have been moving higher over the past week overall, pushing about 5% to the upside on above-average trading volume. Over the past month, shares of the stock have suffered from clear selling pressure, dropping by roughly -15%.
Medical Marijuana Inc pulled in sales of $10.4M in its last reported quarterly financials, representing top-line growth of -38.7%. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($6.3M against $8.8M, respectively).
Real Brands Inc (OTCMKTS: RLBD) has put together a model designed to differentiate itself from other names in the CBD space on multiple levels, including with proprietary technology, branding expertise, credibility driven by affiliation with established research institutions, a team that deeply understands the market, alignment with deep-pocketed funding sources, and a major partnership in place with a billion-dollar listed player.
RLBD has its roots in a reverse merger that took Canadian American Standard Hemp Inc., or “CASH”, onto the public markets last fall. That installed a new leadership team including a new CEO and Chairman, Thomas Kidrin, who was formerly with MariMed Inc (OTCMKTS: MRMD), a publicly traded cannabis company.
In a recent interview, Kidrin notes that RLBD is in the business of proprietary specialized extraction and chromatography to produce 99% pure cannabinoids.
RLBD is over 23% owned by Turning Point Brands, Inc. (NYSE: TPB), a billion-dollar NYSE-listed company that is also a customer of RLBD now for bulk CBD oils and isolates used in Turning Point products. Turning Point has more than 250,000 points of distribution with leading brands such as Zig-Zag®, Stoker’s®, and Beech Nut®.
RLBD also recently brought in the Chief Science Officer of iconic skincare brand, Elizabeth Grant Skin Care, Dr. Adel Rammal, PhD. Rammel will be instrumental in helping to formulate leading-edge branded CBD topicals to be marketed through the company’s Wa Brands segment.
The company is also working on expanding its product lines and has the proprietary technology to produce higher-margin cannabinoid-based products at scale efficiently, which grants RLBD another edge over the competition in establishing itself as a CBD Boom 2.0 winner.
RLBD is also working on an international expansion that will include marketing through international sports celebrities and sports leagues and include a sports wellness product line that Kidrin says is nearing launch.
The company is also working on a line of CBD Beverages and other fresh concepts, which will launch in the next 60-90 days.
Real Brands Inc (OTCMKTS: RLBD) wants to move these new products internationally as well and will seek to market through authentic influencer relationships. The company is in the process of filing Form 10, which should be completed this month, and believes it will be able to uplist shortly after.
RLBD also has deep-pocketed support given that it is almost a quarter owned by TPB, which is a third owned by a multi-billion dollar hedge fund with a vested interest in helping TPB and its major interests secure necessary financing on strong investor-friendly terms.
That may be helping the stock, which has already started to take off to the upside this week, rallying as much as 75% higher on Monday after holding key support at the stock’s 200-day MA last week.
Cronos Group Inc (NASDAQ: CRON) casts itself as an investment firm in the biopharmaceutical space, with a strong emphasis on medical marijuana and cannabis-related research and products. In short, the company seeks to invest in other companies, either licensed or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marijuana for Medical Purposes Regulations (MMPR).
The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment but does not need control.
CRON recently released a Marketing Code designed to responsibly move the emerging cannabis industry forward. Cronos Group believes that those below the legal age of consumption should not be targeted in an adult-use cannabis market. Cronos Group recognizes there is a clear need for standards. That’s why the Company proactively created its own and is sharing its principles publicly as a resource for the industry and policymakers.
“This Marketing Code is an important step toward elevating industry practices. We hope that others within the industry will embrace similar commitments,” said Kurt Schmidt, President, and Chief Executive Officer, Cronos Group. “As policymakers consider how to best regulate a federally legal U.S. cannabis market, we believe these principles reflect the sort of policies necessary to support a trustworthy industry.”
Even with that news, the action hasn’t really heated up in the stock, with shares moving net sideways over the past week.
Cronos Group Inc pulled in sales of $22.2M in its last reported quarterly financials, representing top-line growth of 130.3%. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($1.6B against $263.5M).
DISCLAIMER: EDM Media LLC (EDM), is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. EDM is NOT affiliated in any manner with any company mentioned herein. EDM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses, and may NOT sell, offer to sell or offer to buy any security. EDM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. EDM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed EDM has been compensated five thousand dollars for news coverage of the current press releases issued by Real Brands Inc (OTCMKTS: RLBD) by a third party.
EDM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and EDM undertakes no obligation to update such statements.
EDM Media LLC
Alabama Set To Become the 37th State To Legalize Medical Cannabis
Riding the wave of cannabis legalization that has been sweeping the US for the last few years, Alabama is poised to become the 37th state to implement of comprehensive medical cannabis program. Although the bill is still in review, it’s expected to pass based on strong bipartisan support for loosening cannabis restrictions, coupled with the bill’s landslide win in the state legislature (68-34 and 20-9 respectively).
Are you a cannabis aficionado who would like to learn more this incredible plant, about the best terpenes for sleep, or to gain access to exclusive deals on flowers and other products? If so, make sure to subscribe to The CBD Flowers Weekly Newsletter for the best of the best that this industry has to offer.
Summarizing Alabama’s Compassionate Care Act
Point blank, the bill is likely going to pass. That said, let’s take a closer look at some of the main points of Alabama’s medical cannabis proposal.
Qualifying for the Program
- To legally use and access medicinal cannabis products, patients must apply for and receive a medical cannabis card, which will be granted for one or more of the following medical conditions:
- Autism; cancer-related pain, nausea, or weight loss; Crohn’s; epilepsy; HIV/AIDS-related nausea; persistent nausea that has not significantly responded to other treatments, with exceptions; PTSD; sickle cell anemia; panic disorder; Tourette’s; Parkinson’s disease; spasticity related to multiple sclerosis, a motor neuron disease, or spinal cord injury; terminal illness; or a condition causing intractable or chronic pain “in which conventional therapeutic intervention and opiate therapy is contraindicated or has proved ineffective.”
- The Senate-passed version also includes anxiety, menopause, premenstrual syndrome, and fibromyalgia. The House-passed version includes depression.
- Qualifying patients, caregivers, and medical cannabis establishments and their staff are not subject to criminal or civil penalty for actions authorized by the bill.
- Patients could possess up to 70 daily doses of cannabis (this is vague, and I was unable to find any specific weight limits. Also, no indication whether this is referring to smokable flowers or infused products).
- Patients generally could not be denied organ transplants or other medical care on the basis of medical cannabis.
Physicians’ Role and Regulation
- To certify patients, physicians must be authorized to do so by the State Board of Medical Examiners. They must meet qualifications the board establishes. The House version also requires physicians to pay a fee of up to $300 to certify patients.
- Certifying physicians must complete a four-hour medical cannabis continuing medical education course and complete an exam. The courses can charge up to $500. A two-hour refresher is required every two years.
- The board will develop rules for certifications including requirements for the patient-physician relationship, detailed requirements for informed consent, and how long a certification may be valid, which may not exceed one year.
- Certifying physicians must specify daily dosage and type. This would likely require participating doctors to run afoul of federal law. If this is not revised, it would likely dramatically depress participation.
Limitations and Penalties
- The commission will also determine the maximum daily dosage of THC that can be recommended for each qualifying condition. In most cases, it may not exceed 50 milligrams.
- Raw plant, smoking, vaporization, candies, and baked goods are not allowed. Pills, gelatin cubes, lozenges, oils, suppositories, nebulizers, and patches are.
- Employers could still drug test and prohibit employees from using cannabis.
- Patients could not undertake any task while under the influence of cannabis that would be negligent.
- Cannabis is banned at correctional facilities and schools.
- Health insurance would not have to reimburse for medical cannabis costs.
- Cannabis could not be possessed in a vehicle unless it is in its original package, sealed, and reasonably inaccessible while the vehicle is moving.
Final Thoughts – Alabama Medical Cannabis
Once more, this bill has not yet been signed into law, and medical cannabis is not yet legal in Alabama. The governor is continuing to review all the details, and it is expected to pass, so we’ll make sure to update you as soon as it’s signed. For more articles like this and for access to exclusive deals on flowers and other products, make sure to subscribe to The CBD Flowers Weekly Newsletter.
Next Dimension Podcast – Pico Neo 3, PSVR 2, HTC Vive Pro 2 & Vive Focus 3!
Hong Kong in Talks with China to Stretch Cross-Border Testing of Digital Yuan
Online Cybersecurity Certification Programs
Technoblade’s Minecraft settings
Disney’s streaming growth slows as pandemic lift fades, shares fall
Proof-of-Work Cryptocurrencies Spikes After Elon Musk Ditches Bitcoin
Playbase offers an instant solution to organizing simple and cost-effective competitive gaming platforms
Elon Musk on crypto: to the mooooonnn! And back again
MicroStrategy Acquires an Additional 271 Bitcoins for $15 Million
AlphaESS lance de nouveaux produits et programmes au salon Smart Energy Conference & Exhibition de 2021
US pipeline ransomware attack serves as fair warning to persistent corporate inertia over security
Extra Salt, O PLANO secure wins in cs_summit 8 closed qualifier openers
The World’s Most Interesting Boeing 747 Uses
Valorant Error Code VAN 81: How to Fix
CS:GO Update 188.8.131.52 adds several updates to new map Ancient
Shiba Inu (SHIB) Mania, Dogecoin, Tesla’s Bitcoin Halt and Crypto Market Volatility: The Weekly Recap
How Young Entrepreneur Jeff Clayton Is Innovating the Dropshipping Logistics Industry
Understanding dimensionality reduction in machine learning models
Aero-Engine Coating Market to grow by USD 28.43 million|Key Drivers, Trends, and Market Forecasts|17000+ Technavio Research Reports
Tesla Model S Plaid Sets A New 1/4 Mile Record: 9.23 Seconds
Blockchain1 week ago
Yieldly announces IDO
Aviation1 week ago
JetBlue Hits Back At Eastern Airlines On Ecuador Flights
AI7 days ago
Build a cognitive search and a health knowledge graph using AWS AI services
Esports6 days ago
‘Destroy Sandcastles’ in Fortnite Locations Explained
Blockchain6 days ago
Shiba Inu: Know How to Buy the New Dogecoin Rival
Blockchain1 week ago
“Privacy is a ‘Privilege’ that Users Ought to Cherish”: Elena Nadoliksi
Esports1 week ago
Resident Evil Village: Chamber of Solace Full Items List and Locations
Blockchain News1 week ago
Goldman Sachs Managing Director Reportedly Resigns After Making Millions from Dogecoin
Energy1 week ago
ONE Gas to Participate in American Gas Association Financial Forum
Blockchain7 days ago
Meme Coins Craze Attracting Money Behind Fall of Bitcoin
Blockchain6 days ago
Texas House Passes Bill that Recognizes Crypto Under Commercial Law
Blockchain1 week ago
NYC Comptroller Candidate Suggests Crypto Investments as Inflation Hedge